|
HS Code |
656903 |
| Generic Name | Atropine Sulfate |
| Drug Class | Anticholinergic |
| Chemical Formula | C17H23NO3·H2SO4 |
| Route Of Administration | Intravenous, intramuscular, subcutaneous, ophthalmic |
| Mechanism Of Action | Muscarinic acetylcholine receptor antagonist |
| Indications | Bradycardia, organophosphate poisoning, pre-anesthesia, mydriasis induction |
| Contraindications | Glaucoma, hypersensitivity to atropine, obstructive uropathy |
| Common Side Effects | Dry mouth, blurred vision, tachycardia, urinary retention, constipation |
| Storage Temperature | Controlled room temperature (20°C to 25°C) |
| Prescription Status | Prescription only |
As an accredited Atropine Sulfate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Atropine Sulfate is packaged in a clear, 10 mL amber glass vial, labeled with dosage, concentration, and lot number. |
| Shipping | Atropine Sulfate should be shipped in secure, properly labeled containers that comply with hazardous material regulations. Protect from light, moisture, and extreme temperatures. Use secondary containment to prevent leaks. Follow all national and international guidelines for the transport of pharmaceuticals and hazardous chemicals, ensuring documentation accompanies the shipment. |
| Storage | Atropine sulfate should be stored in a tightly closed, light-resistant container at controlled room temperature, ideally between 20°C and 25°C (68°F–77°F). Protect it from moisture, excessive heat, and freezing conditions. Keep away from incompatible substances and limit access to authorized personnel. Always handle according to relevant safety guidelines and local regulations. |
Applications of Atropine Sulfate in Industrial ManufacturingAs an established manufacturer specializing in high-purity Atropine Sulfate, we supply this critical raw material to regulated downstream sectors where consistently controlled input and traceability are required. Below, we outline the main application scenarios in industrial manufacturing where Atropine Sulfate is incorporated as a core agent, referencing authentic compliance systems, process parameters, and end-product outputs from our customers in the pharmaceutical and animal health industries. 1. Sterile Injectable Antimuscarinic PharmaceuticalsPharmaceutical production lines extensively use Atropine Sulfate to compound injectable solutions indicated for emergency treatment of bradycardia and organophosphate poisoning. Quality assurance in this segment requires strict conformity to pharmacopeial specifications, with automated bulk formulation, inline sterile filtration, and aseptic vial filling steps precisely controlling dosing and excipient balance. The formulation stage adjusts concentration to meet clinical efficiency and regulatory thresholds. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Ophthalmic Diagnostic FormulationsOphthalmic manufacturing divisions integrate Atropine Sulfate into sterile collyrium and eye drop solutions as a cycloplegic agent for pupil dilation during eye examinations and selected therapeutic treatments. Output specifications require pharmaceutical-grade input verified against validated monographs, with process flows emphasizing particulate control, chemical stability with buffering systems, and fill-finish automation to eliminate contamination risk in small volume packaging. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Pre-anesthetic Veterinary Injection ProductsVeterinary pharmaceutical manufacturers employ Atropine Sulfate for injectable formulations designed to reduce salivation and prevent bradycardia in animals undergoing anesthesia. Production mandates traceable sourcing and batch-level quality documentation to align with veterinary GMP and international pharmacopoeia references, using closed-system reactors for solution blending, followed by high-standard sterilization and glass packaging. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Antidote Auto-Injector DevicesDefense and emergency medical device assemblers use Atropine Sulfate as the primary active ingredient in auto-injectors for rapid antidote delivery in field or military environments, specifically for organophosphate and nerve agent exposure. The sourcing process adheres to security-cleared supply chain protocols and compliance with specialized medical device and pharmaceutical regulations. Filling technology incorporates real-time dosing checks and hermetic sealing within ISO Class 7 environments to maintain sterility and dose uniformity. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Atropine Sulfate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Atropine sulfate plays a unique role inside our plant. We produce it with a clear understanding that its journey reaches critical points — hospital wards, ambulances, pharmaceutical labs, and research centers. It’s not just one more molecule. Atropine sulfate represents a key element doctors and pharmacists trust in settings where immediate therapeutic action is essential.
Producing atropine sulfate means more than just mixing raw materials. We take control of the process, starting at the alkaloid extraction from botanical sources. Each step — from purification to final crystallization — keeps us on our feet, adjusting for every environmental shift and impurity challenge. Over years of refining our process, we see how small changes can impact the end product. Fluctuations in reaction chemistry and solvent dryness, variations in raw feed quality, even subtleties in filtering, make a difference. Our operators have long learned to read cues in the process — a shift in color, a crystal structure under the microscope — which tell more than data points alone. We only approve batches when laboratory and production teams agree. Analytical testing checks for precise quantification, residual solvent levels, physical integrity, and purity; our observations never stop at compendial minimums.
What distinguishes our atropine sulfate isn't found in paperwork; it comes out while handling real-world emergencies or critical research. Emergency medicine asks for absolute reliability. When a paramedic draws a dose or a surgeon preps an operating room, they demand substances without doubt. Atropine sulfate blocks muscarinic effects on the nervous system. Doctors reach for it in bradycardia, calm overactive secretions before surgery, or counteract poisoning from organophosphates or nerve gas. There’s little room for error; these scenarios do not forgive imprecision, particulate contamination, or formulation problems.
Because of this, our team believes in real transparency. We frequently initiate dialogue with hospital pharmacists and clinical toxicologists who work with the end result of our chemistry. Experiences from these professionals come back to us not as abstract concepts, but as hard lessons. If nurses perceive inconsistent dissolution or vials fail optical inspection, we track the cause back through the plant. In the past, feedback on ease of solution clarity or vial-to-vial consistency has prompted us to fine-tune our crystallization cooling rate or invest in higher-purity glass ampoules. As a manufacturer, we do not just react; we seek these conversations to drive improvement.
Over decades, we’ve seen various atropine formulations from around the world. Some emphasize price, others speed, many are re-bottled generics with minimal oversight. The difference, as observed by physicians and pharmacists, turns up in the details. One crucial point is control over particle size. We target a fine, consistently dispersed crystalline powder. This allows rapid, complete dissolution whether prepared for injection, eye drops, or research standards. The wrong particle size profile can gum up dissolvers, create cloudy solutions, or force longer prep times — all unacceptable in clinical settings.
We stick with specifications that go beyond pharmacopeia-directed tests. Not every production facility is willing to revalidate process robustness after every plant upgrade. Our operators do. With every equipment swap — whether switching filter media or changing the batch evaporator — we run qualification batches to measure real-world yield, impurity profile, and endpoint reproducibility. This hands-on approach is what gives our partners confidence in every purchase.
Packaging tells another story. Our atropine sulfate arrives in primary containers engineered to withstand variation in transit and long shelf lives. We do not outsource this. Each ampoule, vial, or HDPE drum is filled, sealed, and labeled under our direct oversight, using machine vision inspection paired with manual review. One of the subtle but vital differences we maintain involves headspace control and oxygen exclusion for bulk shipments. Atropine’s stability profile depends on minimizing moisture uptake and oxidative degradation — no shortcuts allowed. We have seen subpar packaging from others lead to yellowing or clumping during extended storage. Our packaging lines have eliminated these issues, as confirmed by our own long-term stability trials and partner feedback.
Medical teams count on atropine sulfate for a variety of uses. In cardiac care, it treats dangerous bradycardia by acting as a competitive antagonist at muscarinic receptors — a proven intervention for stabilizing patients during cardiac emergencies. Surgery teams use it to control secretions and reduce reflexes activated by anesthesia. Out in the field, first responders often carry atropine sulfate autoinjectors as an essential part of their antidote packs for nerve agent exposure or certain insecticide poisonings. Each of these scenarios places specific stresses on the active material and its carrier solution.
We have responded to feedback from medical staff who sometimes deal with unusual environmental situations. In remote clinics or military settings, temperature swings and vibration stress packaging and solubility. To address this, our stability testing doesn’t stick to standard lab conditions. Instead, we simulate temperature cycles, shipping stress, and environmental humidity — giving us a product that keeps its integrity through every link in the distribution chain.
Diagnostic and laboratory users make different demands on atropine sulfate. In the pharmaceutical field, our product often ends up as a benchmark or positive control in research. Analysts demand traceability and batch reproducibility, especially when their data influence regulatory filings or clinical development. We maintain archives of each batch, retain samples, and keep analytical records accessible for years, allowing scientists to reference and compare data anytime. This has seen us chosen over more opaque suppliers, especially when research labs need adherence to strict regulatory guidelines.
Among our various products, atropine sulfate stands out because of its specific model design — tailored for high-stakes injectable and research use. Our flagship model is a sterile, pyrogen-free formulation, produced under GMP conditions and double-tested for bacterial endotoxins. Final material achieves purity consistently above 99%, as measured by HPLC. We routinely check enantiomeric composition and screen for contamination by related alkaloids, which occurs in less controlled processes. Every batch includes a full certificate of analysis — not just for basic compliance, but for total transparency.
Differences between our atropine sulfate and generic versions start early in the process. Many international manufacturers source their raw material from third-party alkaloid suppliers and rely heavily on external purification. In contrast, we oversee extraction, primary purification, and crystallization all under one roof. This approach blocks the entry of unknown contaminants and gives us the flexibility to respond rapidly if analytical feedback points to a potential problem. Product managers and quality analysts run routine in-process checks, using analytical techniques like IR spectroscopy, HPLC-UV, and titration. If a batch drifts outside expected physical or chemical parameters, we halt production for a full root-cause analysis, not just a lab retest.
As a chemical manufacturer, our work does not end with the final batch. Government regulators regularly audit our plant, reviewing training files, production histories, and batch records. We invite these checks because the safety of patients and reliability in clinical environments rest on transparent, traceable, and documented manufacturing practice. Our staff receive ongoing education in regulatory requirements, contamination control, and emergency response. Internal audits and post-market surveillance keep us vigilant even after a batch leaves our warehouse.
We see our place not only as a supplier, but as a stake-holder in every life touched by atropine sulfate. To us, consistency and verifiable quality are non-negotiable. Every year, new challenges arise: novel impurities, evolving pharmacopeial standards, and shifts in global regulatory frameworks — like nitrosamine risk assessments and environmental constraints. We actively invest in method development and stability profiling, always seeking to anticipate, not just react, to new requirements.
Atropine sulfate production doesn’t happen in a vacuum. The primary alkaloid comes from botanical sources, most often Atropa belladonna or related Solanaceae. Unpredictable weather, agricultural disease, and shifts in available acreage can stress raw material price and supply. We address these risks by diversifying our supply base, maintaining long-term relationships with farmers well-versed in ethical practices. Regular audits of our agricultural partners support both traceability and reliability in alkaloid content.
Handling waste streams and protecting workers from potent alkaloids and solvents is a major operational focus. Decades of experience have taught us to keep safety procedures ahead of regulatory minimums — including closed-system handling, engineered ventilation, and personal monitoring. Wastewater is never simply rinse-and-dispose; all production effluent passes through neutralization and filtration before entering municipal streams, and we keep analytical records accessible for inspection.
Growing demand in certain regions and global emergencies, such as mass poisoning events, have tested both the speed and resilience of our supply chain. We constantly improve our planning and packaging lead times, running regular scenario drills to prepare for spikes in demand. We adapt batch scheduling to quickly deliver high volumes of finished materials, and offer emergency batch release when necessary, supported by extra-staffed quality control labs.
Atropine sulfate stands as a legacy product, but we do not let routine settle in. As more health systems aim to decentralize antidote storage and raise emergency preparedness, our R&D group is always looking for ways to make administration easier and manufacturing more sustainable. Feedback from hospital partners pushed us to develop new packaging formats that reduce breakage and accidental exposure. Field clinics and NGOs have called for prefilled syringes and single-dose ampoules; we’re designing this approach into upcoming models.
On the technical front, our analytical chemists actively evaluate non-traditional approaches to detect trace impurities, given increasing regulatory scrutiny worldwide. We’ve implemented spectral fingerprinting as a rapid screening tool before releasing full HPLC or GC analytical data. This lets us rapidly identify even low-level process impurities and points for process improvement. Small details, like switching from solvent-intensive extractions to greener purification steps, make a big impact, especially now as the chemical manufacturing sector faces global pressure to reduce environmental loads.
For us, producing atropine sulfate goes beyond technical mastery or regulatory compliance. Our legacy is built every day in plant walk-throughs, analytical huddles, and conversations with doctors who use the medication in the most demanding situations imaginable. We recognize the weight of responsibility that comes with every bottle and vial. Patients rely on us, usually without their knowledge, but our partners know who stands behind each shipment. We approach each order mindful of the trust placed in our product — from a rural ambulance crew on their third shift in the week, to a clinical pharmacologist running a pivotal study with life-changing endpoints.
Our experience — real, imperfect, gained through the hard moments and the successful ones — drives everything we do. Atropine sulfate is more than just a chemical in our catalog. It represents a promise, renewed every single batch, that each dose is produced with care, tested with dedication, and delivered with the confidence that only hands-on manufacturing expertise can give.